Clinical Trials Directory

Trials / Completed

CompletedNCT03452761

Effects of Exogenous Ketones in Healthy Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Augusta University · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Exogenous ketone supplements in the form of beta-hydroxybutyrate can be utilized as an alternate energy source (in place of glucose) for all cells except red blood cells. Exogenous ketone administration has been shown to be beneficial in terms of reducing oxidative stress, improving neuronal energy supplies, and maintaining normal blood glucose levels. The purpose of this study is to determine the effects and safety of supplementing with exogenous ketones for 6-weeks in healthy college-aged males and females. The results of this proposed study will determine whether exogenous ketone supplementation can be useful in promoting better body composition, energy levels, and blood cholesterol, glucose, and insulin levels.

Detailed description

A total of 22 subjects, male and female, were randomized to either a ketone salt group or a placebo group. Both the participants and investigators were blinded, as the supplements were coded by an external lab. Data was collected at baseline and again in 6-weeks. Participants consumed 2 servings of the assigned supplement daily for 6 weeks. Measures included body composition, blood pressure, questionnaires, blood work (comprehensive metabolic panel, complete blood count, and lipid panel), and a urinalysis. Also, blood ketone levels were assessed before and periodically after consuming the supplemental drink (30 and 60 minutes post drink). These measures were performed at both baseline and 6-weeks later.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKetone SaltsSubjects will take 2 servings of ketone salts daily for 6 weeks

Timeline

Start date
2017-07-14
Primary completion
2017-10-27
Completion
2017-10-27
First posted
2018-03-02
Last updated
2018-03-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03452761. Inclusion in this directory is not an endorsement.